David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity ... a tremendous ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

The Trump administration has resumed collection efforts on student loans, affecting those in default sooner than expected.

"By quantifying both the health and economic benefits of GLP-1 access, this work not only advances the dialogue around obesity management in the U.S. workforce, it also paves the way for scalable ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Ooops... Something went wrong while loading this page.

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, ...

Company to host conference call and webcast today at 8:00 a.m. ET--MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc.